Friday, March 20, 2020

The French hydroxychloroquine study

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial

20 patients were treated, 16 patients (unmatched, nonrandomized) were controls, 6 treated patients lost to followup, in some cases due to worsening

Update:  on March 25, India banned the export of hydroxychloroquine.  And has approved its use prophylactically:
"The Indian government recently permitted prophylactic use of hydroxychloroquine tablets for health care workers as well as people who were in close contact with coronavirus patients — and because of this there could be increased demand and an immediate shortage in the country."


Anonymous said...

The six patients received hydroxychloroquine & azithromycin The six patients 100% treated with hydroxychloroquine and azithromycin combination were virologicaly cured. In movie ending 1 relapses a bit after 100% on day 8.

How soon pills in sufficient quantities available if further proved efficacy of hydroxychloroquine & azithromycin as treatment and secondary as prevention?

Appreciate your helpful physician info Meryl!!


Chopin Etude

Any better grasps on big picture of situation?

Anonymous said...

Chloroquine Use For COVID-19 Shows No Benefit In First Small—But Limited—Controlled Trial

Malaria Drug Chloroquine No Better Than Regular Coronavirus Care, Study Finds
By Michelle Fay Cortez and Claire Che
March 24, 2020

Meryl Nass, M.D. said...

the thing about masks, including bandannas, is while they prevent you inhaling virus, they maintain the virus on their surface. So you carry the virus around with you as you wear them, and they must be handled very carefully. You can't take a bandanna off and then reuse it without washing it. But it may be better than nothing. I wonder how long it will be before CDC, which is telling us to use these alternatives when no PPE are available, informs us how much benefit vs risk they provide.